Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs10261625 | chr7:135173544 | C/T | 2.07E-9 | 488 | 30.77 | 32.4 | 3.03 | KM Plot |
PRAD | rs10266715 | chr7:135155366 | C/T | 1.34E-8 | 494 | 9.45 | 32.7 | 30.3 | KM Plot |
PRAD | rs10267977 | chr7:135159392 | G/A | 2.06E-9 | 491 | 30.53 | 32.52 | 3.03 | KM Plot |
PRAD | rs10269360 | chr7:135147425 | A/C | 9.67E-9 | 494 | 30.77 | 32.52 | 3.98 | KM Plot |
PRAD | rs10276768 | chr7:135064346 | A/G | 1.8E-9 | 492 | 30.8 | 31.9 | 3.03 | KM Plot |
PRAD | rs10418303 | chr19:53143616 | C/T | 1.22E-8 | 494 | 30.8 | 31.18 | 26.13 | KM Plot |
PRAD | rs1042120 | chr19:49983673 | C/T | 7.13E-7 | 479 | 30.33 | 33.1 | 24.25 | KM Plot |
PRAD | rs10422888 | chr19:45453763 | A/G | 1.09E-5 | 487 | 30.3 | 31.13 | 45.2 | KM Plot |
PRAD | rs10424979 | chr19:53144356 | C/T | 1.23E-8 | 493 | 30.8 | 31.18 | 26.13 | KM Plot |
PRAD | rs10444067 | chr10:99442836 | G/A | 2.24E-7 | 475 | 31.37 | 31.35 | 24.67 | KM Plot |
PRAD | rs10458163 | chr6:3863987 | T/C | 7.97E-8 | 470 | 31.93 | 29.23 | 23.08 | KM Plot |
PRAD | rs10458299 | chr7:135052348 | C/T | 3.05E-10 | 484 | 30.9 | 31.9 | 2.33 | KM Plot |
PRAD | rs10469891 | chr2:33944025 | T/C | 3.42E-5 | 489 | 30.77 | 33.22 | 24.72 | KM Plot |
PRAD | rs10474812 | chr5:7320374 | A/G | 1.08E-8 | 489 | 30.9 | 30.93 | 10.07 | KM Plot |
PRAD | rs10474813 | chr5:7320805 | G/A | 0 | 489 | 30.9 | 31.12 | 4.87 | KM Plot |